These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
| x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| ¨ TRANSACTION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
Nevada
|
88-0126444
|
|
|
(State of Other Jurisdiction of Incorporation or
Organization)
|
(I.R.S. Employer
Identification Number)
|
|
|
c/o Paragon Capital LP
110 East 59
th
Street, 22
nd
Floor
New York, NY
|
10022
|
|
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
|
Large accelerated filer
|
o
|
Accelerated filer
|
o
|
|
Non-accelerated filer
|
o
|
Smaller reporting company
|
x
|
|
Page
|
||||
|
PART I – FINANCIAL INFORMATION
|
||||
|
Item 1.
|
Financial Statements
|
1 | ||
|
Item 2.
|
Management’s Discussion and Analysis of Financial Condition and Plan of Operations
|
7 | ||
|
Item 3.
|
Quantitative and Qualitative Disclosures About Market Risk
|
9 | ||
|
Item 4.
|
Controls and Procedures
|
9 | ||
|
PART II – OTHER INFORMATION
|
||||
|
Item 1.
|
Legal Proceedings
|
10 | ||
|
Item 1A.
|
Risk Factors
|
10 | ||
|
Item 2.
|
Unregistered Sale of Equity Securities and Use of Proceeds
|
10 | ||
|
Item 3.
|
Defaults Upon Senior Securities
|
10 | ||
|
Item 4.
|
Mine Safety Disclosures
|
10 | ||
|
Item 5.
|
Other Information
|
10 | ||
|
Item 6.
|
Exhibits
|
11 | ||
|
SIGNATURES
|
12 | |||
|
(A DEVELOPMENT STAGE COMPANY)
|
|||||||||
|
BALANCE SHEETS
|
|||||||||
|
(Unaudited)
|
|||||||||
|
January 31,
2014
|
April 30,
2013
|
||||||||
|
ASSETS
|
|||||||||
|
Current assets
|
|||||||||
|
Cash
|
$ | 2,010 | $ | 9,218 | |||||
|
Total current assets
|
2,010 | 9,218 | |||||||
|
Total assets
|
$ | 2,010 | $ | 9,218 | |||||
|
LIABILITIES AND STOCKHOLDERS' DEFICIT
|
|||||||||
|
Current liabilities
|
|||||||||
|
Accounts payable
|
$ | 17,788 | $ | 18,861 | |||||
|
Due to related party
|
95,000 | 75,000 | |||||||
|
Total current liabilities
|
112,788 | 93,861 | |||||||
|
Total liabilities
|
112,788 | 93,861 | |||||||
|
Commitments and contingencies
|
- | - | |||||||
|
Stockholders' deficit
|
|||||||||
|
Preferred stock, $0.0001 par value, authorized 10,000,000 shares,
zero issued
|
- | - | |||||||
|
Common stock, $0.0001 par value, authorized 100,000,000 shares;
2,390,083 shares issued and 2,390,081 shares outstanding
|
239 | 239 | |||||||
|
Additional paid-in capital
|
4,228,717 | 4,228,717 | |||||||
|
Treasury stock, 2 shares, at cost
|
(52,954 | ) | (52,954 | ) | |||||
|
Accumulated deficit
|
(4,050,503 | ) | (4,050,503 | ) | |||||
|
Accumulated deficit during the development stage
|
(236,278 | ) | (210,143 | ) | |||||
|
Total stockholders' deficit
|
(110,779 | ) | (84,644 | ) | |||||
|
Total liabilities and stockholders' deficit
|
$ | 2,010 | $ | 9,218 | |||||
|
See accompanying notes to financial statements.
|
|||||||||
|
PREVENTION INSURANCE.COM
|
|
(A DEVELOPMENT STAGE COMPANY)
|
|
STATEMENTS OF OPERATIONS
|
|
(Unaudited)
|
|
For the three months ended
January 31,
|
For the nine months ended
January 31,
|
From May 1, 2009
(re-entrance into development
stage) to
January 31,
2014
|
||||||||||||||||||
|
2014
|
2013
|
2014
|
2013
|
|||||||||||||||||
|
Revenue
|
$ | - | $ | - | $ | - | $ | - | $ | - | ||||||||||
|
Cost of goods sold
|
- | - | - | - | - | |||||||||||||||
|
Gross profit
|
- | - | - | - | - | |||||||||||||||
|
General and administrative expenses
|
10,344 | 9,218 | 26,135 | 21,190 | 236,278 | |||||||||||||||
|
Net loss
|
$ | (10,344 | ) | $ | (9,218 | ) | $ | (26,135 | ) | $ | (21,190 | ) | $ | (236,278 | ) | |||||
|
Loss per common shares - basic and diluted
|
$ | (0.00 | ) | $ | (0.00 | ) | $ | (0.01 | ) | $ | (0.01 | ) | ||||||||
|
Weighted average number of common shares outstanding - basic and diluted
|
2,390,081
|
2,390,081
|
2,390,081
|
2,390,081
|
||||||||||||||||
|
PREVENTION INSURANCE.COM
|
|
(A DEVELOPMENT STAGE COMPANY)
|
|
STATEMENTS OF CASH FLOWS
|
|
(Unaudited)
|
|
From May 1, 2009
|
||||||||||||
|
For the nine months ended
|
(re-entrance into
development
stage)
|
|||||||||||
|
January 31,
|
to January 31, | |||||||||||
|
2014
|
2013
|
2014
|
||||||||||
|
Cash flows from operating activities:
|
||||||||||||
|
Net loss
|
$ | (26,135 | ) | $ | (21,190 | ) | $ | (236,278 | ) | |||
|
Adjustments to reconcile net loss to net
cash used in operating activities:
|
||||||||||||
|
Increase (decrease) in accounts payable
|
(1,074 | ) | (2,820 | ) | 9,035 | |||||||
|
Net cash used in operating activities
|
(27,208 | ) | (24,010 | ) | (227,243 | ) | ||||||
|
Cash flows from financing activities:
|
||||||||||||
|
Proceeds from related party advances
|
20,000 | 20,000 | 95,000 | |||||||||
|
Proceeds from issuance of warrants
|
- | - | 130,000 | |||||||||
|
Net cash provided by financing activities
|
$ | 20,000 | 20,000 | 225,000 | ||||||||
|
Net change in cash
|
(7,208 | ) | (4,010 | ) | (2,243 | ) | ||||||
|
Cash, beginning of period
|
9,218 | 4,343 | 4,253 | |||||||||
|
Cash, end of period
|
$ | 2,010 | $ | 333 | $ | 2,010 | ||||||
|
Supplemental disclosure of cash flow information:
|
||||||||||||
|
Taxes paid
|
$ | - | $ | - | $ | - | ||||||
|
Interest paid
|
$ | - | $ | - | $ | - | ||||||
|
(Unaudited)
|
|
Nine Months
Ended
January 31,
2014
|
Nine Months
Ended
January 31,
2013
|
From May 1, 2009
(re-entrance into development stage)
to January 31,
2014
|
||||||||||
|
Net Cash Used in Operating Activities
|
$ | (27,208 | ) | $ | (24,010 | ) | $ | (236,590 | ) | |||
|
Net Cash Used in Investing Activities
|
$ | - | $ | - | - | |||||||
|
Net Cash Provided by Financing Activities
|
$ | 20,000 | $ | 20,000 | $ | 225,000 | ||||||
|
Net Change in Cash
|
$ | (7,208 | ) | $ | (4,010 | ) | $ | (11,590 | ) | |||
|
●
|
We were unable to maintain any segregation of duties within our business operations due to our reliance on a single individual fulfilling the role of sole officer and director. While this control deficiency did not result in any audit adjustments to our 2013 or 2012 interim or annual financial statements, it could have resulted in a material misstatement that might have been prevented or detected by a segregation of duties. Accordingly we have determined that this control deficiency constitutes a material weakness.
|
|
Exhibit
|
|
Description
|
|
3.1
|
Articles of Incorporation, as amended.
(1)
|
|
| 3.2 |
Certificate of Amendment to Articles of Incorporation
.(2)
|
|
| 3.3 |
Bylaws.
(1)
|
|
|
31.1
|
|
Certification of the Company’s Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, with respect to the registrant’s Quarterly Report on Form 10-Q for the quarter ended January 31, 2014.
|
|
|
|
|
|
31.2
|
|
Certification of the Company’s Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, with respect to the registrant’s Quarterly Report on Form 10-Q for the quarter ended January 31, 2014.
|
|
32.1
|
Certification of the Company’s Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
32.2
|
Certification of the Company’s Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
| 101.INS | XBRL Instance Document | |
| 101.SCH | XBRL Taxonomy Extension Schema | |
| 101.CAL | XBRL Taxonomy Extension Calculation Linkbase | |
| 101.DEF | XBRL Taxonomy Extension Definition Linkbase | |
| 101.LAB | XBRL Taxonomy Extension Label Linkbase | |
| 101.PRE | XBRL Taxonomy Extension Presentation Linkbase |
|
Dated: March 17, 2014
|
PREVENTION INSURANCE.COM
|
|
| /s/ Alan P. Donenfeld | ||
|
Alan P. Donenfeld
President, CEO and Director
Principal Executive Officer
Principal Financial/Accounting Officer
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|